The trial results highlight the potential for patients taking GLP-1 drugs to lose too much weight, which could produce side effects and health problems that must be balanced against any benefits of weight loss, Dr
What matters clinically is whether those symptoms are mild and manageable or significant enough to warrant slowing the pace further
Healthcare systems can implement additional safeguards, including electronic prescribing systems with built-in dose range checking, patient education materials in multiple formats (written, video, pictorial), and follow-up contact after initiation or dose escalation to assess tolerance and adherence
L., Lara, D
Available published data do not contraindicate breast feeding
3032 Updated guidelines now recommend metabolic-bariatric surgery for patients with body mass index 30 kg/m 2 or greater with metabolic disease, including MASH